Pembrolizumab

Leila Khoja; Marcus O. Butler; S. Peter Kang; Scot Ebbinghaus; Anthony M. Joshua

doi:10.1186/s40425-015-0078-9

Article info

PDF

Review

Pembrolizumab

Free

Authors

Leila Khoja Department of Medical OncologyPrincess Margaret Cancer Centre 610 University Avenue M5G 2M9 Toronto ON Canada PubMed articles Google scholar articles
Marcus O. Butler Department of Medical OncologyPrincess Margaret Cancer Centre 610 University Avenue M5G 2M9 Toronto ON Canada PubMed articles Google scholar articles
S. Peter Kang Merck & Co., Inc. Kenilworth NJ USA PubMed articles Google scholar articles
Scot Ebbinghaus Merck & Co., Inc. Kenilworth NJ USA PubMed articles Google scholar articles
Anthony M. Joshua Department of Medical OncologyPrincess Margaret Cancer Centre 610 University Avenue M5G 2M9 Toronto ON Canada PubMed articles Google scholar articles

↵e 416-946-4501 Anthony.Joshua{at}uhn.ca

View Full Text

Citation

Khoja L, Butler MO, Kang SP, et al

Pembrolizumab

Journal for ImmunoTherapy of Cancer 2015;3:36. doi: 10.1186/s40425-015-0078-9

Publication history

Received February 18, 2015
Accepted June 24, 2015
First published August 18, 2015.

Online issue publication

February 16, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password